BE667333A - - Google Patents

Info

Publication number
BE667333A
BE667333A BE667333A BE667333A BE667333A BE 667333 A BE667333 A BE 667333A BE 667333 A BE667333 A BE 667333A BE 667333 A BE667333 A BE 667333A BE 667333 A BE667333 A BE 667333A
Authority
BE
Belgium
Application number
BE667333A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE667333A publication Critical patent/BE667333A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE667333A 1964-07-23 1965-07-23 BE667333A (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DESC035513 1964-07-23
DESC037200 1965-06-10
DESC037199 1965-06-10

Publications (1)

Publication Number Publication Date
BE667333A true BE667333A (en:Method) 1966-01-24

Family

ID=27212324

Family Applications (1)

Application Number Title Priority Date Filing Date
BE667333A BE667333A (en:Method) 1964-07-23 1965-07-23

Country Status (12)

Country Link
US (1) US3423413A (en:Method)
BE (1) BE667333A (en:Method)
BR (1) BR6571550D0 (en:Method)
CH (1) CH494229A (en:Method)
DE (2) DE1620449C3 (en:Method)
DK (1) DK121376B (en:Method)
ES (1) ES315729A1 (en:Method)
GB (1) GB1115390A (en:Method)
IL (1) IL24007A (en:Method)
NL (1) NL143569B (en:Method)
NO (1) NO122124B (en:Method)
SE (1) SE339228B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946843A (en) * 1987-07-10 1990-08-07 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531485A (en) * 1967-08-14 1970-09-29 American Home Prod Aryl-substituted diazabicycloalkanes
DE2436883C2 (de) * 1974-07-29 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4404382A (en) * 1980-09-17 1983-09-13 The Upjohn Company Piperazinyl-substituted imidazoles
DE3132916A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS5879983A (ja) 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
WO2002036695A1 (de) * 2000-10-31 2002-05-10 Basf Drucksysteme Gmbh Verwendung von hyperverzweigten polyurethanen zur herstellung von druckfarben
JP2005532991A (ja) 2002-01-10 2005-11-04 ニューロジェン・コーポレーション メラニン凝集ホルモン受容体リガンド:置換2−(4−ベンジル−ピペラジン−1−イルメチル)−及び2−(4−ベンジル−ジアゼパン−1−イルメチル)−1h−ベンゾイミダゾールアナログ
CA2472470A1 (en) 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
AR066165A1 (es) * 2007-09-18 2009-07-29 Univ Stanford Metodos de tratamiento de una infeccion viral de la familia flaviviridae, composiciones para el tratamiento de una infeccion viral de la familia flaviviridae y ensayos de control para identificar composiciones para el tratamiento de una infeccion viral de la familia flaviviridae
US9101628B2 (en) * 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
CN102448458B (zh) * 2009-03-18 2015-07-22 小利兰·斯坦福大学理事会 治疗黄病毒科病毒感染的方法和组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302847A (en:Method) * 1963-01-10

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946843A (en) * 1987-07-10 1990-08-07 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines
US5011842A (en) * 1987-07-10 1991-04-30 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines for treating allergic diseases
US5086056A (en) * 1987-07-10 1992-02-04 Janssen Pharmaceutica N.V. 2-(heterocyclylalkyl)imidazopyridines

Also Published As

Publication number Publication date
NO122124B (en:Method) 1971-05-24
US3423413A (en) 1969-01-21
DE1620449B2 (de) 1973-07-26
NL143569B (nl) 1974-10-15
DE1470319B2 (de) 1975-09-18
DE1620450A1 (de) 1970-02-19
DE1620450B2 (de) 1975-05-22
DE1620449C3 (de) 1974-02-21
DE1620449A1 (de) 1970-04-30
DE1470319A1 (de) 1969-10-02
SE339228B (en:Method) 1971-10-04
IL24007A (en) 1969-06-25
NL6509573A (en:Method) 1966-01-24
GB1115390A (en) 1968-05-29
ES315729A1 (es) 1966-02-16
BR6571550D0 (pt) 1973-08-14
CH494229A (de) 1970-07-31
DK121376B (da) 1971-10-11
DE1620450C3 (de) 1976-01-02

Similar Documents

Publication Publication Date Title
AU4679664A (en:Method)
BE642654A (en:Method)
BE642212A (en:Method)
BE432268A (en:Method)
BE47396A (en:Method)
BE483969A (en:Method)
BE507097A (en:Method)
BE518974A (en:Method)
BE554195A (en:Method)
BE564626A (en:Method)
BE584699A (en:Method)
BE603534A (en:Method)
BE642741A (en:Method)
BE613833A (en:Method)
BE621510A (en:Method)
BE622126A (en:Method)
BE623398A (en:Method)
BE626083A (en:Method)
BE626684A (en:Method)
BE627057A (en:Method)
BE627390A (en:Method)
BE627931A (en:Method)
BE628611A (en:Method)
BE629793A (en:Method)
BE632875A (en:Method)